Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated-Reference-Cited by-同舟云学术

Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated

Published:2016-10 Issue:10 Volume:22 Page:1851-1860
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Abboud Ramzi,Keller Jesse,Slade Michael,DiPersio John F.,Westervelt Peter,Rettig Michael P.,Meier Stephanie,Fehniger Todd A.,Abboud Camille N.,Uy Geoffrey L.,Vij Ravi,Trinkaus Kathryn M.,Schroeder Mark A.,Romee Rizwan

Funder

Washington University School of Medicine

Washington University Institute of Clinical and Translational Sciences

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference46 articles.

1. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning;Raiola;Biol Blood Marrow Transplant,2013

2. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry;Gragert;N Engl J Med,2014

3. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation;Bashey;J Clin Oncol,2013